NCT05828433

Brief Summary

Benign paroxysmal positional vertigo (BPPV) is a common inner ear disorder characterized by brief episodes of vertigo caused by changes in head position. The condition can cause significant func-tional impairment and reduced quality of life. BPPV is especially common among diabetic patients. The Epley-Canalith Repositioning Procedure (CRP) and Vestibular Rehabilitation Therapy (VRT) are two commonly used interventions for the treatment of BPPV. The objective of this paper is to determine the effective therapy among Epley-Canalith Repositioning Procedure and Vestibular Rehabilitation for improving balance and posture control in Diabetic patients with Benign Parox-ysmal Positional Vertigo. Thirty subjects with Diabetes Mellitus (Type 2) suffering from Benign Paroxysmal Positional Vertigo (BPPV) were recruited for the study and randomly assigned to groups A and B, underwent Canalith Repositioning Procedure and Vestibular Rehabilitation Therapy respectively. The outcome measures of the study were Vertigo Symptom Scale- Short Form (VSS-sf) score and Berg Balance Scale Form (BBS) score assessed at pre -treatment (pre) and 4 weeks post treatment (post).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 7, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 25, 2023

Completed
Last Updated

April 25, 2023

Status Verified

April 1, 2023

Enrollment Period

1 year

First QC Date

March 21, 2023

Last Update Submit

April 12, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Vertigo symptom scale - short form

    VSS consisting of 36 items addresses frequency and severity of dizziness symptoms within the last 12 months. Both a long (VSS-lf) and short a form (VSS-sf) is available. There are 15 items in the VSS-sf. The VSS-sf exhibits high internal consistency (alpha=0.9) and r=0.52 is the construct validity. It has high test -retest reliability is ICC VSS-sf = 0.88, VSS-V=0.90, VSS-A=0.90

    4 weeks

  • Berg Balance Scale

    It is used to test if a patient can securely balance himself while doing a series of prede-termined tasks. It consists of 14 items, each of which has a 5-point ordinal scale rang-ing from 0 to 4, with 0 denoting the lowest degree of function and 4 denoting the high-est level. The relative intra-rater reliability of the BBS with a pooled estimate of 0.98 (95% CI 0.97 to 0.99). Relative inter-rater reliability of the BBS with a pooled estimate of 0.97 (95% CI 0.96 to 0.98)

    4 weeks

Study Arms (2)

Epley-Canalith Repositioning

EXPERIMENTAL

Step 1: The patient was brought down with the head tilted 45 degrees towards the af-fected canal as in Hallpike test. The neck was extended. Step 2: The head was rotated 90 degrees towards the unaffected side. The neck was extended. Step 3: The head and body were rotated by further 90 degrees from the previous positions (now face down). The neck was in neutral position. Step 4: The patient was brought into a sitting position while having their head turned constantly in the direction of the unaffected side. Step 5: The head was turn forward and the chin was kept 20° down for a minute

Other: Epley-Canalith Repositioning

Vestibular Rehabilitation Therapy

EXPERIMENTAL

Habituation exercises Gaze stability exercises and balance training

Other: Vestibular Rehabilitation Therapy

Interventions

Epley-Canalith Repositioning The intervention was given for approximately 15min, for 2 times in a week, for 4 weeks.

Epley-Canalith Repositioning

Vestibular Rehabilitation Therapy Habituation exercises: The patients were asked to repeat the exercises 5 -10 times for 5 to 10 min, for 2 days in a week, for 4 weeks. Gaze stability exercises and balance training: The exercises were performed in 3 sets or 5 repetitions, for 2 days in a week, for 4 weeks.

Vestibular Rehabilitation Therapy

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are diagnosed with posterior canal BPPV by ENT physician
  • Patients diagnosed with diabetes mellitus (Type 2) by the physician through laboratory investigations
  • Both male and female
  • Age between 20 to 70 years
  • Positive Dix -Hallpike test
  • Nystagmus lasting less than 60 seconds
  • Willing to participate in the study
  • Minimum score of 25/56 in Berg Balance Scale

You may not qualify if:

  • Patients taking antivertigo drugs
  • Treated for similar vertigo experience
  • Disease of different origin that may cause vertigo like migraine, multiple sclerosis, stroke, traumatic brain injury
  • CRP has been done before
  • Other causes of peripheral vertigo such as Meniere's disease, vestibular neuritis, labyrinthitis and peri lymphatic fistula
  • Pathologies contraindicated for Dix- Hallpike manoeuvre like prolapse inter-vertebral disk, cervical spine instability, cervical myelopathy
  • Previous cervical spine surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jazan University

Jizan, Saudi Arabia

Location

MeSH Terms

Conditions

Benign Paroxysmal Positional Vertigo

Condition Hierarchy (Ancestors)

VertigoVestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 21, 2023

First Posted

April 25, 2023

Study Start

January 7, 2022

Primary Completion

January 17, 2023

Study Completion

January 17, 2023

Last Updated

April 25, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations